TOKYO -- Japan will soon move to support the domestic antibiotics industry as part of public and private efforts to reduce the supply chain's heavy exposure to China.
Supply Chain
Japan to subsidize antibiotics supply chain to reduce China exposure
Production of active ingredients has moved abroad for cost reasons
Japanese pharmaceutical companies typically use imported active ingredients to produce finished antibiotics. © Reuters
Read Next
Latest on Supply Chain
